DGIdb - NAMODENOSON Drug Record

NAMODENOSON chembl:CHEMBL431733 Antineoplastic

Alternate Names:

NAMODENOSON
CF-102
CI-IB-MECA
CHLORO-IB-MECA
CL-IB-MECA

Drug Info:

FDA Approval	not approved
Drug Class	Small molecule
Drug Indications	antineoplastic agent

(0 More Sources)

Publications:

Choi WJ et al., 2009, Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists., Bioorg Med Chem
Kim Y et al., 2009, Novel 2- and 4-substituted 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric modulators of the A3 adenosine receptor., J Med Chem

NAMODENOSON ADORA3

Interaction Score: 8.14

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Adenosine A3 receptor agonist

Direct Interaction yes

Trial Name CF-102

PMIDs:
19879151 19284749

Sources:
DTC TdgClinicalTrial ChemblInteractions
NAMODENOSON NFE2L2

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC

TdgClinicalTrial: CF-102
- Version: January-2014
Alternate Names:

Drug Info:

Drug Indications antineoplastic agent

Drug Class Small molecule

FDA Approval not approved

Publications:

DTC: CF102

Version: 02-September-2020

Alternate Names:

CHEMBL431733 ChEMBL Drug ID

Drug Info:

Publications:

Choi WJ et al., 2009, Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists., Bioorg Med Chem

Kim Y et al., 2009, Novel 2- and 4-substituted 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric modulators of the A3 adenosine receptor., J Med Chem

ChemblDrugs: chembl:CHEMBL431733
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:
ChemblInteractions: CHEMBL431733
- Version: chembl_23
Alternate Names:

Drug Info:

Publications: